<DOC>
	<DOCNO>NCT01112800</DOCNO>
	<brief_summary>Anthracycline antibiotic include chemotherapy regimen approximately 82 % patient bone cancer 44 % soft tissue sarcoma diagnose childhood adolescence . Impaired cardiac function occur treatment anthracyclines . The frequency impairment increase increase cumulative dose . There inadequate data regard relationship doxorubicin administration change serum level cardiac troponin T ( cTn-T ) I ( cTn-I ) , N-terminal ( NT ) brain natriuretic peptide ( BNP ) , tissue Doppler image parameter . This non-therapeutic study proposes prospective , single arm study serial change tissue Doppler imaging parameter , cTn-T NT-BNP child adolescent malignant bone soft tissue tumor whose planned chemotherapy include treatment ≥ 375 mg/m2 doxorubicin . The propose study rigorously evaluate usefulness serial determination tissue Doppler imaging , cTn-T NT-BNP early identification anthracycline-related myocardial injury . Demonstration one marker identify subclinical myocardial damage biomarker tissue Doppler imaging parameter exhibit dose-response relationship cumulative doxorubicin dose would facilitate intervention trial patient risk anthracycline cardiomyopathy .</brief_summary>
	<brief_title>Markers Anthracycline-Related Cardiac Muscle Injury</brief_title>
	<detailed_description>The primary aim proposal serially evaluate imaging test previously untreated patient osteosarcoma , Ewing 's Sarcoma Family Tumors ( ESFT ) , rhabdomyosarcoma intermediate high-risk non-rhabdomyosarcoma soft tissue sarcomas whose planned treatment include cumulative doxorubicin dose ≥ 375 mg/m2 determine serial level one potential marker cardiac muscle injury obtain prior infusion doxorubicin completion chemotherapy correlate increase cumulative anthracycline exposure . The secondary aim study estimate proportion patient decrease ( evaluation j - evaluation j+1 ) peak longitudinal systolic strain ( ε ) strain rate ( SR ) , peak radial systolic ε SR , peak radial systolic myocardial velocity peak longitudinal systolic myocardial velocity among shorten fraction ( SF ) ≥ 29 % prior infusion anthracycline . This study evaluate whether serum level cTn-T and/or NT-BNP increase follow doxorubicin administration . The study evaluate whether serum level cTn-T and/or NT-BNP increase increase cumulative doxorubicin dose .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<criteria>Between 0 21 year age Diagnosis osteosarcoma , Ewing Sarcoma Family Tumors , rhabdomyosarcoma , intermediate highrisk nonrhabdomyosarcoma soft tissue sarcoma Planned treatment include administration cumulative anthracycline dose ≥ 375 mg/m2 Pregnant Females Patients history cancer prior current malignancy Patients whose treatment include radiation therapy volume include heart</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Anthracycline</keyword>
	<keyword>Cardiac Muscle Injury</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Doppler Imaging</keyword>
	<keyword>Intermediate non-rhabdomyosarcoma soft tissue sarcoma</keyword>
	<keyword>High-risk non-rhabdomyosarcoma soft tissue sarcoma</keyword>
</DOC>